• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant

LeanTaaS Secures $130M for ML Platform to Help Hospitals Achieve Operational Excellence

by Fred Pennic 12/10/2020 Leave a Comment

LeenTaaS Secures $130M for ML Platform to Help Hospitals Achieve Operational Excellence

What You Should Know: - LeanTaaS raises $130 million in Series D Funding to strengthen its machine learning platform to continue helping hospitals achieve operational excellence during a time where they are facing mounting financial pressures due to COVID-19.  - LeanTaaS provides software solutions that combine lean principles, predictive analytics, and machine learning to transform hospital and infusion center operations to improve operational efficiencies, increase access, and
Read More

Banner Health, WellSpan, Others Invest in Virtual Maternity Care Platform Babyscripts

by Jasmine Pennic 12/09/2020 Leave a Comment

Banner Health, WellSpan, Others Invest in Virtual Maternity Care Platform Babyscripts

What You Should Know: - Virtual maternity care platform Babyscripts announced a new round of investments from Banner Health, CU Healthcare Innovation Fund, The Froedtert & Medical College of Wisconsin Health Network, and WellSpan Health - Using internet-connected devices for remote monitoring, Babyscripts offers risk-specific experiences to allow providers to manage up to 90% of pregnancies virtually, allowing doctors to detect risk more quickly and automate elements of
Read More

Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms

by Jasmine Pennic 12/09/2020 Leave a Comment

Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms

What You Should Know: - Lightspeed Venture Partners, the VC behind Nest and GrubHub, is leading a $10 million round for Freespira, an FDA-cleared digital therapeutic proven to significantly reduce or eliminate panic attacks and PTSD symptoms by training users to normalize respiratory irregularities. - In 28 days, Freespira can reduce or eliminate panic attacks and PTSD symptoms from home with just a tablet, sensor, and custom app. There’s no medicine with possible side effects and no need
Read More

Pair Team Emerges Out of Stealth with $2.7M to Automate Primary Care Operations

by Fred Pennic 12/09/2020 Leave a Comment

Pair Team Emerges Out of Stealth with $2.7M to Automate Primary Care Operations

What You Should Know: - San Francisco-based digital health startup Pair Team emerges out of stealth with $2.7M in seed funding backed by Kleiner Perkins, Craft Ventures, & YC. - Pair Team provides both a remote team and AI that automates workflows, provides infrastructure & improves medical practices — efficiencies and billing as you’d expect, but all driving toward value-based, quality patient care. - Pair’s wrap-around technology tripled the rate of annual wellness visits
Read More

Pear Therapeutics Raises $80M to Advance Prescription Digital Therapeutics

by Jasmine Pennic 12/08/2020 Leave a Comment

Pear Therapeutics Raises $80M to Advance Prescription Digital Therapeutics

What You Should Know: - Pear Therapeutics today announced that it has successfully closed an $80 million Series D financing led by SoftBank Vision Fund 2. -  Pear is the leader in prescription digital therapeutics and the first company to receive FDA authorization for a prescription digital therapeutic (PDT) to treat disease. - Pear currently has three FDA authorized therapies, reSET, reSET-O and Somryst, for substance use disorder, opioid use disorder, and chronic insomnia,
Read More

M&A: Ro Acquires On-Demand, In-Home Platform Workpath

by Fred Pennic 12/08/2020 Leave a Comment

M&A: Ro Acquires On-Demand, In-Home Platform Workpath

What You Should Know: - Ro announced it has acquired Workpath, a technology platform that powers on-demand, in-home healthcare and diagnostics services nationwide. - Through this acquisition, Ro’s platform will now uniquely bring together a patient's doctor, pharmacy, and diagnostics/lab--offering a personalized, end-to-end experience with no insurance required. - Ro is also announcing a partnership with Quest Diagnostics, which operates more than 2,200 locations nationwide, to
Read More

Medical AI Startup SegMed Nabs $2M to Aggregate Medical Data for Research

by Fred Pennic 12/04/2020 Leave a Comment

Medical AI Startup SegMed Nabs $2M to Aggregate Medical Data for Research

What You Should Know: - Segmed emerges out of stealth and has secured $2M in seed funding to empower medical AI efforts through easy access to high-quality, structured and anonymized training data sets. - The healthcare industry is amassing data at an unprecedented rate but unless this data is standardized, labeled, and curated for use by patients and clinicians, it is not beneficial. - Segmed simplifies the process by enabling AI developers to achieve faster development times,
Read More

Backed by Redesign Health, MedArrive Launches with $4.5M in Funding for Care Management Platform

by Fred Pennic 12/04/2020 Leave a Comment

Backed by Redesign Health, MedArrive Launches with $4.5M in Funding for Care Management Platform

What You Should Know: - With $4.5 million in funding from Kleiner Perkins and Define Ventures, and backed by Redesign Health, MedArrive is poised to bridge the virtual care gap and make affordable at-home care the new norm. - Co-founded by the former head of Uber Health, MedArrive enables healthcare providers to seamlessly extend care services into the home, unlocking access to high-quality healthcare for more people at a fraction of the cost. - MedArrive’s fully integrated care
Read More

Backed by Khosla Ventures, Rubedo Life Sciences Secures $12M for Drug Discovery Platform

by Jasmine Pennic 12/04/2020 Leave a Comment

Backed by Khosla Ventures, Rubedo Life Sciences Secures $12M for Drug Discovery Platform

What You Should Know: - Biopharma startup Rubedo Life Sciences raises $12M to develop a broad portfolio of innovative therapies engineered to target cells for chronic age-related diseases. - Rubedo’s proprietary ALEMBIC™ drug discovery platform, has generated a novel pipeline of therapeutic candidates that selectively target senescent cells, pro-inflammatory and pro-fibrotic cell populations that result from a variety of cellular stress and damage. Rubedo Life Sciences, a
Read More

Everlywell Secures $175M to Expand Position in At-Home Testing Market

by Jasmine Pennic 12/03/2020 Leave a Comment

Everlywell Announces $175 Million Financing to Expand Consumer Lab Testing and Digital Health Offerings

What You Should Know: - Everlywell secures $175M in Series D funding to expand its virtual care offerings, scale its testing and infrastructure, drive clinical research and disease management through testing, and grow its national leadership position in the at-home testing market. - Since launching in 2016, more than one million people have used Everlywell's tests and digital platform to manage their health and wellness. As more people turn toward digital platforms for their health
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 108
  • Go to page 109
  • Go to page 110
  • Go to page 111
  • Go to page 112
  • Interim pages omitted …
  • Go to page 266
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |